Evaluation of a health and social care programme to improve outcomes following critical illness: a multicentre study.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
02 2023
Historique:
received: 31 10 2021
accepted: 10 02 2022
pubmed: 23 3 2022
medline: 17 1 2023
entrez: 22 3 2022
Statut: ppublish

Résumé

At present, clinicians aiming to support patients through the challenges after critical care have limited evidence to base interventions. Evaluate a multicentre integrated health and social care intervention for critical care survivors. A process evaluation assessed factors influencing the programme implementation. This study evaluated the impact of the Intensive Care Syndrome: Promoting Independence and Return to Employment (InS:PIRE) programme. We compared patients who attended this programme with a usual care cohort from the same time period across nine hospital sites in Scotland. The primary outcome was health-related quality of life (HRQoL) measured via the EuroQol 5-dimension 5-level instrument, at 12 months post hospital discharge. Secondary outcome measures included self-efficacy, depression, anxiety and pain. 137 patients who received the InS:PIRE intervention completed outcome measures at 12 months. In the usual care cohort, 115 patients completed the measures. The two cohorts had similar baseline demographics. After adjustment, there was a significant absolute increase in HRQoL in the intervention cohort in relation to the usual care cohort (0.12, 95% CI 0.04 to 0.20, This multicentre evaluation of a health and social care programme designed for survivors of critical illness appears to show benefit at 12 months following hospital discharge.

Identifiants

pubmed: 35314485
pii: thoraxjnl-2021-218428
doi: 10.1136/thoraxjnl-2021-218428
pmc: PMC9872253
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-168

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Chest. 2011 Dec;140(6):1534-1539
pubmed: 21737490
Lancet Respir Med. 2020 Dec;8(12):1175-1176
pubmed: 33197389
BMJ. 2009 Oct 16;339:b3723
pubmed: 19837741
Intensive Care Med. 2018 Dec;44(12):2038-2047
pubmed: 30467678
Cochrane Database Syst Rev. 2018 Nov 02;11:CD012701
pubmed: 30388297
Nurs Crit Care. 2009 Sep-Oct;14(5):254-63
pubmed: 19706076
Thorax. 2017 Sep;72(9):856-858
pubmed: 28213591
Crit Care Med. 2018 Sep;46(9):1393-1401
pubmed: 29787415
Crit Care. 2016 May 29;20(1):165
pubmed: 27236480
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Crit Care Med. 2020 Dec;48(12):1871-1880
pubmed: 33060502
Health Qual Life Outcomes. 2007 Dec 21;5:70
pubmed: 18154669
Crit Care Med. 2020 Nov;48(11):1670-1679
pubmed: 32947467
J Crit Care. 2018 Aug;46:141-148
pubmed: 29929705
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
PLoS One. 2017 Nov 29;12(11):e0188028
pubmed: 29186177
Crit Care Explor. 2020 Nov 19;2(11):e0273
pubmed: 34124686
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1122-1130
pubmed: 28537429
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Crit Care Med. 2019 Sep;47(9):1194-1200
pubmed: 31241499
Crit Care Med. 2019 Jan;47(1):e21-e27
pubmed: 30422863
Am J Crit Care. 2019 Sep;28(5):393-400
pubmed: 31474610
Crit Care. 2019 May 2;23(1):153
pubmed: 31046813
Crit Care Med. 2013 Aug;41(8):1832-43
pubmed: 23782967
Crit Care Med. 2012 Feb;40(2):502-9
pubmed: 21946660
Crit Care. 2018 Nov 23;22(1):310
pubmed: 30466485
Ann Am Thorac Soc. 2020 Oct;17(10):1326-1329
pubmed: 32716636
JAMA Intern Med. 2015 Jun;175(6):901-10
pubmed: 25867659
Intensive Care Med. 2010 Dec;36(12):2090-3
pubmed: 20689933
J Intensive Care Soc. 2017 Nov;18(4):289-293
pubmed: 29123558

Auteurs

Philip Henderson (P)

Academic unit of Anaesthesia, Critical Care, and Peri-operative Medicine, University of Glasgow, Glasgow, UK philip.henderson@ggc.scot.nhs.uk.

Tara Quasim (T)

Academic unit of Anaesthesia, Critical Care, and Peri-operative Medicine, University of Glasgow, Glasgow, UK.
Department of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.

Martin Shaw (M)

Academic unit of Anaesthesia, Critical Care, and Peri-operative Medicine, University of Glasgow, Glasgow, UK.
Clinical Physics, NHS Greater Glasgow and Clyde, Glasgow, UK.

Pamela MacTavish (P)

Department of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.

Helen Devine (H)

Department of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.

Malcolm Daniel (M)

Department of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.

Fiona Nicolson (F)

Department of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.

Peter O'Brien (P)

Department of Anaesthesia and Intensive Care Medicine, University Hospital Crosshouse, Kilmarnock, UK.

Ashley Weir (A)

Department of Anaesthesia and Intensive Care Medicine, University Hospital Crosshouse, Kilmarnock, UK.

Laura Strachan (L)

Department of Intensive Care Medicine, Queen Elizabeth University Hospital, Glasgow, UK.

Lorraine Senior (L)

Department of Anaesthesia and Intensive Care Medicine, University Hospital Monklands, Airdrie, UK.

Phil Lucie (P)

Department of Anaesthesia and Intensive Care Medicine, University Hospital Wishaw, North Lanarkshire, UK.

Lynn Bollan (L)

Department of Intensive Care Medicine, Adult Critical Care Unit, University Hospital Wishaw, North Lanarkshire, UK.

Jane Duffty (J)

Department of Anaesthesia and Intensive Care Medicine, University Hospital Hairmyres, East Kilbride, UK.

Lucy Hogg (L)

Department of Intensive Care Medicine, Victoria Hospital, Kirkcaldy, UK.

Colette Ross (C)

Department of Intensive Care Medicine, Victoria Hospital, Kirkcaldy, UK.

Malcolm Sim (M)

Department of Intensive Care Medicine, Queen Elizabeth University Hospital, Glasgow, UK.

Radha Sundaram (R)

Department of Intensive Care Medicine, Royal Alexandra Hospital, Paisley, UK.

Theodore J Iwashyna (TJ)

Department of Pulmonary and Critical Care, Ann Arbor Health System, Ann Arbor, Michigan, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Joanne McPeake (J)

Academic unit of Anaesthesia, Critical Care, and Peri-operative Medicine, University of Glasgow, Glasgow, UK.
Department of Intensive Care Medicine, Glasgow Royal Infirmary, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH